Loading…
CIK 0001617201 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("prosight-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $2.3M | 0.5% | 17,000 SH | New |
| ADC THERAPEUTICS SA | SHS | $29.9M | 6.2%Prev: 7.0% | 8,477,338 SH | Increased+1,005,035 SH |
| ADICET BIO INC | COM NEW | $2.1M | 0.4% | 250,244 SH | New |
| ALNYLAM PHARMACEUTICALS INC | COM | $6.8M | 1.4% | 17,109 SH | New |
| AMICUS THERAPEUTICS INC | COM | $16.4M | 3.4%Prev: 3.1% | 1,150,000 SH | Increased-559,533 SH |
| AVANTOR INC | COM | $10.3M | 2.1% | 898,499 SH | New |
| BOSTON SCIENTIFIC CORP | COM | $20.0M | 4.1%Prev: 1.7% | 210,000 SH | Increased+133,900 SH |
| BRIDGEBIO PHARMA INC | COM | $2.3M | 0.5%Prev: 3.2% | 30,000 SH | Decreased-234,500 SH |
| CAREDX INC | COM | $4.7M | 1.0%Prev: 1.7% | 250,000 SH | Decreased-254,030 SH |
| CONCENTRA GROUP HOLDINGS PAR | COMMON STOCK | $17.5M | 3.6%Prev: 3.0% | 891,030 SH | Increased+281,030 SH |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $5.6M | 1.2%Prev: 1.0% | 683,872 SH | Increased+340,472 SH |
| CRINETICS PHARMACEUTICALS IN | COM | $12.2M | 2.5%Prev: 3.2% | 262,904 SH | Decreased-65,780 SH |
| GALAPAGOS NV | SPON ADR | $35.1M | 7.3%Prev: 9.3% | 1,074,112 SH | Decreased-75,888 SH |
| GENEDX HOLDINGS CORP | COM CL A | $7.2M | 1.5% | 55,000 SH | New |
| ICON PLC | SHS | $20.0M | 4.1%Prev: 4.5% | 110,000 SH | Increased+500 SH |
| IMMUNOVANT INC | COM | $6.2M | 1.3%Prev: 2.6% | 243,404 SH | Decreased-455,068 SH |
| JANUX THERAPEUTICS INC | COM | $33.0M | 6.8%Prev: 4.9% | 2,392,523 SH | Increased+1,527,173 SH |
| KURA ONCOLOGY INC | COM | $26.3M | 5.4%Prev: 5.7% | 2,529,600 SH | Increased-228,916 SH |
| LABCORP HOLDINGS INC | COM SHS | $8.7M | 1.8% | 34,532 SH | New |
| MEIRAGTX HLDGS PLC | COM | $25.5M | 5.3%Prev: 7.8% | 3,209,788 SH | Decreased-879,721 SH |
| NEKTAR THERAPEUTICS | COM NEW | $23.4M | 4.8% | 554,633 SH | New |
| ONKURE THERAPEUTICS INC | COM CL A | $2.4M | 0.5%Prev: 0.2% | 816,909 SH | Increased+548,950 SH |
| ORTHOPEDIATRICS CORP | COM | $2.4M | 0.5%Prev: 1.3% | 136,741 SH | Decreased-171,966 SH |
| PHREESIA INC | COM | $16.5M | 3.4% | 977,152 SH | New |
| PLIANT THERAPEUTICS INC | COM | $1.9M | 0.4%Prev: 0.0% | 1,555,744 SH | Increased+1,535,257 SH |
| PROCEPT BIOROBOTICS CORP | COM | $43.4M | 9.0%Prev: 0.6% | 1,380,000 SH | Increased+1,303,009 SH |
| REIN THERAPEUTICS INC | COM NEW | $513K | 0.1%Prev: 0.2% | 442,600 SH | Decreased-125,298 SH |
| ROCKET PHARMACEUTICALS INC | COM | $2.6M | 0.5%Prev: 1.0% | 743,942 SH | Decreased-524,023 SH |
| ROIVANT SCIENCES LTD | SHS | $13.6M | 2.8%Prev: 4.7% | 627,162 SH | Decreased-708,338 SH |
| SELECT MED HLDGS CORP | COM | $15.4M | 3.2%Prev: 2.6% | 1,035,086 SH | Increased+160,171 SH |
| SHATTUCK LABS INC | COM | $8.7M | 1.8%Prev: 3.0% | 2,381,502 SH | Decreased-3,069,693 SH |
| SYNDAX PHARMACEUTICALS INC | COM | $14.0M | 2.9%Prev: 3.6% | 665,000 SH | Decreased-338,400 SH |
| TECTONIC THERAPEUTIC INC | COM | $4.9M | 1.0%Prev: 1.4% | 235,000 SH | Decreased-144,254 SH |
| TEMPUS AI INC | CL A | $2.1M | 0.4% | 35,000 SH | New |
| TERNS PHARMACEUTICALS INC | COM | $3.8M | 0.8% | 95,000 SH | New |
| TRUEBLUE INC | COM | $2.0M | 0.4%Prev: 0.1% | 442,554 SH | Increased+363,078 SH |
| VEEVA SYS INC | CL A COM | $20.1M | 4.2% | 90,133 SH | New |
| ZYMEWORKS INC | COM | $14.0M | 2.9%Prev: 3.0% | 530,393 SH | Increased-219,218 SH |
| 13F-HR |
| 0001420506-26-001799 |
| $580.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001420506-25-002021 | $410.1M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001420506-26-001036 | $609.8M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001420506-25-001167 | $304.3M | View |